FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to new substituted pyrazino-quinolines of formula: 
, wherein the values R1, R2, R3, R4, R5, R5a, R6, R7, R8, R9, R10, R11, R12, R13, R14, X and Y are presented in clause one of the patent claim, and to their pharmaceutically acceptable salts.
EFFECT: compounds can be used for treating cancer.
14 cl, 24 dwg, 2 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOUNDS FOR TREATING TRIPLE-NEGATIVE BREAST CANCER AND OVARIAN CANCER | 2019 |
|
RU2776897C2 |
| COMPOUNDS FOR TREATING CANCER | 2010 |
|
RU2581367C2 |
| METHODS FOR INCREASING STABILISATION OF HYPOXYA INDUCED FACTOR-1 ALPHA | 2010 |
|
RU2521251C2 |
| NEW COMPOUND AND PHARMACEUTICAL COMPOSITION FOR INCREASING ANTICANCER ACTIVITY, CONTAINING SAID COMPOUND | 2019 |
|
RU2781282C1 |
| TRICYCLIC COMPOUNDS AS INHIBITORS OF IMMUNOSUPPRESSION MEDIATED BY TRYPTOPHAN METABOLIZATION | 2014 |
|
RU2667509C2 |
| 8-ANILINOIMIDAZOPYRIDINES AND METHODS FOR USE THEREOF | 2008 |
|
RU2498985C2 |
| ENPP1 INHIBITORS AND METHODS OF MODULATING THE IMMUNE RESPONSE | 2018 |
|
RU2800798C2 |
| BENZOTHIOPHENE SELECTIVE ESTROGEN RECEPTOR BLOCKERS | 2016 |
|
RU2747802C2 |
| TRYPTOLIDE DERIVATIVE, METHOD FOR ITS PREPARATION AND APPLICATION | 2018 |
|
RU2753036C1 |
| COMPOSITIONS AND METHODS OF TREATING CANCER | 2006 |
|
RU2547148C2 |
